MRSA coverage in pneumonia: which antibiotic is a key option?

MRSA coverage in pneumonia: which antibiotic is a key option?

• A. Linezolid
• B. Ceftriaxone
• C. Amoxicillin
• D. Doxycycline

Answer: (A)

When treating pneumonia with suspected MRSA, you need an antibiotic with strong activity against MRSA and good lung penetration. Linezolid fits best because it reliably targets MRSA and reaches high concentrations in lung tissue, and it has both IV and easily switchable oral dosing (high bioavailability), which helps with step-down therapy. This makes it a preferred option for MRSA pneumonia, including hospital- or ventilator-associated cases. The other drugs here don’t provide the same level of MRSA coverage in pneumonia: ceftriaxone and amoxicillin lack MRSA activity, and doxycycline has limited reliability for serious or hospital-associated MRSA pneumonia. Also note linezolid can cause thrombocytopenia with prolonged use and may interact with serotonergic meds, so monitoring is important.

When treating pneumonia with suspected MRSA, you need an antibiotic with strong activity against MRSA and good lung penetration. Linezolid fits best because it reliably targets MRSA and reaches high concentrations in lung tissue, and it has both IV and easily switchable oral dosing (high bioavailability), which helps with step-down therapy. This makes it a preferred option for MRSA pneumonia, including hospital- or ventilator-associated cases. The other drugs here don’t provide the same level of MRSA coverage in pneumonia: ceftriaxone and amoxicillin lack MRSA activity, and doxycycline has limited reliability for serious or hospital-associated MRSA pneumonia. Also note linezolid can cause thrombocytopenia with prolonged use and may interact with serotonergic meds, so monitoring is important.